Oranoxis™ launches ToxWipe-Oral™ K2 and ToxStick K2™ for on-site drugs of abuse testing of K2/synthetic cannabinoids.

Oranoxis™ launches ToxWipe-Oral™ K2 and ToxStick K2™ for on-site drugs of abuse testing of K2/synthetic cannabinoids. ToxWipe-Oral™ K2 is one of the first rapid test devices on the market capable of detecting K2/synthetic cannabinoids in oral fluid, and ToxStick K2™ detects major K2/synthetic cannabinoids in urine with high sensitivity.